25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

41L (Laboratorios Farmaceuticos Rovi S.A) Stock Analysis
Buy, Hold or Sell?

Let's analyze Laboratorios Farmaceuticos Rovi S.A together

I guess you are interested in Laboratorios Farmaceuticos Rovi S.A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Laboratorios Farmaceuticos Rovi S.A’s Financial Insights
  • 📈 Technical Analysis (TA) – Laboratorios Farmaceuticos Rovi S.A’s Price Targets

I'm going to help you getting a better view of Laboratorios Farmaceuticos Rovi S.A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Laboratorios Farmaceuticos Rovi S.A

I send you an email if I find something interesting about Laboratorios Farmaceuticos Rovi S.A.

1. Quick Overview

1.1. Quick analysis of Laboratorios Farmaceuticos Rovi S.A (30 sec.)










1.2. What can you expect buying and holding a share of Laboratorios Farmaceuticos Rovi S.A? (30 sec.)

How much money do you get?

How much money do you get?
€5.19
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€11.37
Expected worth in 1 year
€14.89
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
€7.94
Return On Investment
14.2%

For what price can you sell your share?

Current Price per Share
€56.00
Expected price per share
€51.50 - €65.95
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Laboratorios Farmaceuticos Rovi S.A (5 min.)




Live pricePrice per Share (EOD)
€56.00
Intrinsic Value Per Share
€6.11 - €38.89
Total Value Per Share
€17.48 - €50.25

2.2. Growth of Laboratorios Farmaceuticos Rovi S.A (5 min.)




Is Laboratorios Farmaceuticos Rovi S.A growing?

Current yearPrevious yearGrowGrow %
How rich?$684m$639.2m$44.7m6.5%

How much money is Laboratorios Farmaceuticos Rovi S.A making?

Current yearPrevious yearGrowGrow %
Making money$160.9m$200.3m-$39.3m-24.4%
Net Profit Margin17.9%20.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Laboratorios Farmaceuticos Rovi S.A (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Laboratorios Farmaceuticos Rovi S.A?

Welcome investor! Laboratorios Farmaceuticos Rovi S.A's management wants to use your money to grow the business. In return you get a share of Laboratorios Farmaceuticos Rovi S.A.

First you should know what it really means to hold a share of Laboratorios Farmaceuticos Rovi S.A. And how you can make/lose money.

Speculation

The Price per Share of Laboratorios Farmaceuticos Rovi S.A is €56.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Laboratorios Farmaceuticos Rovi S.A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Laboratorios Farmaceuticos Rovi S.A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €11.37. Based on the TTM, the Book Value Change Per Share is €0.88 per quarter. Based on the YOY, the Book Value Change Per Share is €0.53 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €1.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Laboratorios Farmaceuticos Rovi S.A.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps3.155.6%3.155.6%3.876.9%3.836.8%3.225.7%2.474.4%
Usd Book Value Change Per Share1.041.9%1.041.9%0.631.1%1.091.9%1.312.3%1.913.4%
Usd Dividend Per Share1.302.3%1.302.3%1.572.8%1.342.4%0.931.7%0.701.2%
Usd Total Gains Per Share2.334.2%2.334.2%2.193.9%2.434.3%2.244.0%2.614.7%
Usd Price Per Share72.04-72.04-71.22-61.99-63.23-52.06-
Price to Earnings Ratio22.89-22.89-18.42-16.94-22.29-28.25-
Price-to-Total Gains Ratio30.86-30.86-32.46-26.28-29.21-26.17-
Price to Book Ratio5.39-5.39-5.77-4.94-5.78-5.19-
Price-to-Total Gains Ratio30.86-30.86-32.46-26.28-29.21-26.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share65.8672
Number of shares15
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.300.93
Usd Book Value Change Per Share1.041.31
Usd Total Gains Per Share2.332.24
Gains per Quarter (15 shares)35.0233.59
Gains per Year (15 shares)140.08134.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
178621305678124
2156124270112157258
3234187410168235392
4312249550224313526
5389311690280392660
6467373830336470794
7545435970392548928
862349811104486261062
970156012505047051196
1077962213905607831330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Laboratorios Farmaceuticos Rovi S.A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8810.8810%0.533+65%0.926-5%1.110-21%1.624-46%
Book Value Per Share--11.36911.3690%10.488+8%10.604+7%9.430+21%8.309+37%
Current Ratio--3.1253.1250%2.549+23%2.598+20%2.684+16%2.757+13%
Debt To Asset Ratio--0.3010.3010%0.321-6%0.343-12%0.347-13%0.341-12%
Debt To Equity Ratio--0.4380.4380%0.475-8%0.533-18%0.539-19%0.526-17%
Dividend Per Share--1.1041.1040%1.332-17%1.137-3%0.794+39%0.594+86%
Enterprise Value--2882424752.5002882424752.5000%2881319840.300+0%2435841554.900+18%2587064944.480+11%2128828174.043+35%
Eps--2.6762.6760%3.287-19%3.259-18%2.734-2%2.100+27%
Ev To Sales Ratio--3.7743.7740%3.474+9%3.045+24%3.884-3%3.590+5%
Free Cash Flow Per Share--1.4871.4870%1.120+33%2.054-28%1.654-10%1.008+48%
Free Cash Flow To Equity Per Share--1.4871.4870%1.120+33%1.071+39%0.758+96%0.609+144%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--38.885----------
Intrinsic Value_10Y_min--6.110----------
Intrinsic Value_1Y_max--2.457----------
Intrinsic Value_1Y_min--1.406----------
Intrinsic Value_3Y_max--8.480----------
Intrinsic Value_3Y_min--3.562----------
Intrinsic Value_5Y_max--15.825----------
Intrinsic Value_5Y_min--4.975----------
Market Cap--3132906752.5003132906752.5000%3137709840.3000%2723906888.233+15%2852391944.480+10%2361783602.614+33%
Net Profit Margin--0.1790.1790%0.205-13%0.210-14%0.202-11%0.167+7%
Operating Margin----0%-0%0.103-100%0.153-100%0.133-100%
Operating Ratio--1.1391.1390%1.1410%1.110+3%1.1400%1.199-5%
Pb Ratio4.925-9%5.3875.3870%5.773-7%4.936+9%5.781-7%5.186+4%
Pe Ratio20.926-9%22.88822.8880%18.421+24%16.943+35%22.290+3%28.247-19%
Price Per Share56.000-9%61.25061.2500%60.550+1%52.700+16%53.760+14%44.257+38%
Price To Free Cash Flow Ratio37.660-9%41.19041.1900%54.043-24%35.147+17%87.325-53%51.072-19%
Price To Total Gains Ratio28.212-9%30.85730.8570%32.462-5%26.283+17%29.213+6%26.175+18%
Quick Ratio--0.8280.8280%0.717+15%0.721+15%0.731+13%0.744+11%
Return On Assets--0.1650.1650%0.213-23%0.202-18%0.184-11%0.149+11%
Return On Equity--0.2390.2390%0.316-24%0.313-24%0.285-16%0.230+4%
Total Gains Per Share--1.9851.9850%1.865+6%2.062-4%1.904+4%2.218-11%
Usd Book Value--684007348.000684007348.0000%639257642.800+7%645503656.867+6%586003776.360+17%521047694.486+31%
Usd Book Value Change Per Share--1.0371.0370%0.627+65%1.089-5%1.305-21%1.910-46%
Usd Book Value Per Share--13.37313.3730%12.336+8%12.473+7%11.092+21%9.773+37%
Usd Dividend Per Share--1.2981.2980%1.567-17%1.337-3%0.934+39%0.699+86%
Usd Enterprise Value--3390307993.8913390307993.8910%3389008396.161+0%2865036836.873+18%3042905787.697+11%2503927698.309+35%
Usd Eps--3.1483.1480%3.866-19%3.833-18%3.216-2%2.470+27%
Usd Free Cash Flow--89460595.80089460595.8000%68290172.000+31%125591891.533-29%102568874.320-13%61922057.171+44%
Usd Free Cash Flow Per Share--1.7491.7490%1.318+33%2.416-28%1.946-10%1.185+48%
Usd Free Cash Flow To Equity Per Share--1.7491.7490%1.318+33%1.259+39%0.891+96%0.717+144%
Usd Market Cap--3684924922.2913684924922.2910%3690574314.1610%3203859281.940+15%3354983405.097+10%2777929873.395+33%
Usd Price Per Share65.867-9%72.04272.0420%71.219+1%61.986+16%63.233+14%52.055+38%
Usd Profit--160999432.200160999432.2000%200348027.000-20%198732712.333-19%169612509.560-5%130757649.914+23%
Usd Revenue--898321573.800898321573.8000%975668485.800-8%945255482.400-5%818539692.560+10%699689454.571+28%
Usd Total Gains Per Share--2.3352.3350%2.194+6%2.426-4%2.239+4%2.609-11%
 EOD+4 -2MRQTTM+0 -0YOY+23 -143Y+16 -225Y+23 -1510Y+31 -7

3.3 Fundamental Score

Let's check the fundamental score of Laboratorios Farmaceuticos Rovi S.A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.926
Price to Book Ratio (EOD)Between0-14.925
Net Profit Margin (MRQ)Greater than00.179
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.828
Current Ratio (MRQ)Greater than13.125
Debt to Asset Ratio (MRQ)Less than10.301
Debt to Equity Ratio (MRQ)Less than10.438
Return on Equity (MRQ)Greater than0.150.239
Return on Assets (MRQ)Greater than0.050.165
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Laboratorios Farmaceuticos Rovi S.A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.895
Ma 20Greater thanMa 5055.210
Ma 50Greater thanMa 10053.662
Ma 100Greater thanMa 20052.864
OpenGreater thanClose55.550
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Laboratorios Farmaceuticos Rovi S.A

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Laboratorios Farmaceuticos Rovi S.A earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • A Net Profit Margin of 17.9% means that €0.18 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 17.9%. The company is making a huge profit. +2
  • The TTM is 17.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ17.9%TTM17.9%0.0%
TTM17.9%YOY20.5%-2.6%
TTM17.9%5Y20.2%-2.3%
5Y20.2%10Y16.7%+3.5%
4.3.1.2. Return on Assets

Shows how efficient Laboratorios Farmaceuticos Rovi S.A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • 16.5% Return on Assets means that Laboratorios Farmaceuticos Rovi S.A generated €0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 16.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 16.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.5%TTM16.5%0.0%
TTM16.5%YOY21.3%-4.8%
TTM16.5%5Y18.4%-1.9%
5Y18.4%10Y14.9%+3.5%
4.3.1.3. Return on Equity

Shows how efficient Laboratorios Farmaceuticos Rovi S.A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • 23.9% Return on Equity means Laboratorios Farmaceuticos Rovi S.A generated €0.24 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 23.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 23.9%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ23.9%TTM23.9%0.0%
TTM23.9%YOY31.6%-7.7%
TTM23.9%5Y28.5%-4.6%
5Y28.5%10Y23.0%+5.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Laboratorios Farmaceuticos Rovi S.A.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Laboratorios Farmaceuticos Rovi S.A is operating .

  • Measures how much profit Laboratorios Farmaceuticos Rovi S.A makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y15.3%-15.3%
5Y15.3%10Y13.3%+2.1%
4.3.2.2. Operating Ratio

Measures how efficient Laboratorios Farmaceuticos Rovi S.A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.14 means that the operating costs are €1.14 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 1.139. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.139. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.139TTM1.1390.000
TTM1.139YOY1.141-0.002
TTM1.1395Y1.140-0.001
5Y1.14010Y1.199-0.059
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Laboratorios Farmaceuticos Rovi S.A.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Laboratorios Farmaceuticos Rovi S.A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 3.13 means the company has €3.13 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 3.125. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.125. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.125TTM3.1250.000
TTM3.125YOY2.549+0.577
TTM3.1255Y2.684+0.441
5Y2.68410Y2.757-0.073
4.4.3.2. Quick Ratio

Measures if Laboratorios Farmaceuticos Rovi S.A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • A Quick Ratio of 0.83 means the company can pay off €0.83 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 0.828. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.828. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.828TTM0.8280.000
TTM0.828YOY0.717+0.111
TTM0.8285Y0.731+0.097
5Y0.73110Y0.744-0.013
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Laboratorios Farmaceuticos Rovi S.A.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Laboratorios Farmaceuticos Rovi S.A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to industry mean.
  • A Debt to Asset Ratio of 0.30 means that Laboratorios Farmaceuticos Rovi S.A assets are financed with 30.1% credit (debt) and the remaining percentage (100% - 30.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 0.301. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.301. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.301TTM0.3010.000
TTM0.301YOY0.321-0.019
TTM0.3015Y0.347-0.046
5Y0.34710Y0.341+0.005
4.5.4.2. Debt to Equity Ratio

Measures if Laboratorios Farmaceuticos Rovi S.A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • A Debt to Equity ratio of 43.8% means that company has €0.44 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The MRQ is 0.438. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.438. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.438TTM0.4380.000
TTM0.438YOY0.475-0.037
TTM0.4385Y0.539-0.101
5Y0.53910Y0.526+0.013
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Laboratorios Farmaceuticos Rovi S.A generates.

  • Above 15 is considered overpriced but always compare Laboratorios Farmaceuticos Rovi S.A to the  industry mean.
  • A PE ratio of 22.89 means the investor is paying €22.89 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The EOD is 20.926. Based on the earnings, the company is fair priced.
  • The MRQ is 22.888. Based on the earnings, the company is fair priced.
  • The TTM is 22.888. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD20.926MRQ22.888-1.962
MRQ22.888TTM22.8880.000
TTM22.888YOY18.421+4.467
TTM22.8885Y22.290+0.598
5Y22.29010Y28.247-5.957
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The EOD is 37.660. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 41.190. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 41.190. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD37.660MRQ41.190-3.531
MRQ41.190TTM41.1900.000
TTM41.190YOY54.043-12.852
TTM41.1905Y87.325-46.135
5Y87.32510Y51.072+36.254
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Laboratorios Farmaceuticos Rovi S.A is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 5.39 means the investor is paying €5.39 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Laboratorios Farmaceuticos Rovi S.A:

  • The EOD is 4.925. Based on the equity, the company is fair priced.
  • The MRQ is 5.387. Based on the equity, the company is overpriced. -1
  • The TTM is 5.387. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.925MRQ5.387-0.462
MRQ5.387TTM5.3870.000
TTM5.387YOY5.773-0.386
TTM5.3875Y5.781-0.394
5Y5.78110Y5.186+0.595
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets832,022
Total Liabilities250,482
Total Stockholder Equity572,028
 As reported
Total Liabilities 250,482
Total Stockholder Equity+ 572,028
Total Assets = 832,022

Assets

Total Assets832,022
Total Current Assets489,606
Long-term Assets342,416
Total Current Assets
Cash And Cash Equivalents 27,186
Short-term Investments 227
Net Receivables 129,471
Inventory 329,954
Other Current Assets 2,687
Total Current Assets  (as reported)489,606
Total Current Assets  (calculated)489,525
+/- 81
Long-term Assets
Property Plant Equipment 286,622
Intangible Assets 33,950
Long-term Assets Other 65
Long-term Assets  (as reported)342,416
Long-term Assets  (calculated)320,637
+/- 21,779

Liabilities & Shareholders' Equity

Total Current Liabilities156,651
Long-term Liabilities93,831
Total Stockholder Equity572,028
Total Current Liabilities
Short Long Term Debt 17,842
Accounts payable 86,851
Other Current Liabilities 5,248
Total Current Liabilities  (as reported)156,651
Total Current Liabilities  (calculated)109,941
+/- 46,710
Long-term Liabilities
Long term Debt 80,503
Capital Lease Obligations Min Short Term Debt16,065
Long-term Liabilities Other 2,746
Long-term Liabilities  (as reported)93,831
Long-term Liabilities  (calculated)99,314
+/- 5,483
Total Stockholder Equity
Retained Earnings 486,213
Total Stockholder Equity (as reported)572,028
Total Stockholder Equity (calculated)486,213
+/- 85,815
Other
Capital Stock3,074
Common Stock Shares Outstanding 51,149
Net Debt 71,159
Net Invested Capital 670,373
Net Working Capital 332,955
Property Plant and Equipment Gross 531,838



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
0
0
0
402,700
511,211
574,439
732,676
878,703
799,884
832,022
832,022799,884878,703732,676574,439511,211402,700000
   > Total Current Assets 
154,083
167,072
168,167
254,004
317,885
364,578
506,362
623,073
509,331
489,606
489,606509,331623,073506,362364,578317,885254,004168,167167,072154,083
       Cash And Cash Equivalents 
0
0
0
95,511
67,426
53,162
99,035
124,945
25,322
27,186
27,18625,322124,94599,03553,16267,42695,511000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
227
227000000000
       Net Receivables 
59,584
56,664
50,601
62,200
89,978
81,951
157,632
181,281
143,314
129,471
129,471143,314181,281157,63281,95189,97862,20050,60156,66459,584
       Inventory 
63,859
67,386
75,492
94,861
158,811
227,199
245,473
311,944
337,968
329,954
329,954337,968311,944245,473227,199158,81194,86175,49267,38663,859
       Other Current Assets 
1,328
1,612
1,327
1,344
1,587
2,181
2,331
2,789
0
2,687
2,68702,7892,3312,1811,5871,3441,3271,6121,328
   > Long-term Assets 
0
0
0
148,696
193,326
209,861
226,314
255,630
290,553
342,416
342,416290,553255,630226,314209,861193,326148,696000
       Property Plant Equipment 
81,803
82,822
89,056
95,837
131,608
155,395
181,775
215,541
253,652
286,622
286,622253,652215,541181,775155,395131,60895,83789,05682,82281,803
       Intangible Assets 
0
0
0
34,650
45,079
41,413
38,558
35,744
33,902
33,950
33,95033,90235,74438,55841,41345,07934,650000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
65
65000000000
> Total Liabilities 
0
0
0
115,228
188,825
200,739
261,700
357,324
256,390
250,482
250,482256,390357,324261,700200,739188,825115,228000
   > Total Current Liabilities 
59,226
76,442
73,223
87,512
106,709
122,889
190,388
293,887
199,843
156,651
156,651199,843293,887190,388122,889106,70987,51273,22376,44259,226
       Short Long Term Debt 
0
0
0
17,635
9,112
2,028
2,959
8,238
8,060
17,842
17,8428,0608,2382,9592,0289,11217,635000
       Accounts payable 
37,278
50,783
43,396
49,512
70,073
65,187
99,403
130,455
107,593
86,851
86,851107,593130,45599,40365,18770,07349,51243,39650,78337,278
       Other Current Liabilities 
2,441
1,626
1,512
8,989
13,678
27,829
59,969
116,359
0
5,248
5,2480116,35959,96927,82913,6788,9891,5121,6262,441
   > Long-term Liabilities 
0
0
0
27,716
82,116
77,850
71,312
63,437
56,547
93,831
93,83156,54763,43771,31277,85082,11627,716000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
20,871
17,546
17,663
17,856
18,792
16,065
16,06518,79217,85617,66317,54620,8710000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
2,746
2,746000000000
       Deferred Long Term Liability 
3,083
4,240
8,429
8,371
7,929
7,487
7,045
6,603
0
0
006,6037,0457,4877,9298,3718,4294,2403,083
> Total Stockholder Equity
0
0
0
287,472
322,386
373,700
470,976
520,012
539,387
572,028
572,028539,387520,012470,976373,700322,386287,472000
   Common Stock
3,000
3,000
3,000
3,364
3,364
3,364
3,364
3,241
0
0
003,2413,3643,3643,3643,3643,0003,0003,000
   Retained Earnings Total Equity0000000000
   Accumulated Other Comprehensive Income 0000000000
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 00-8-2-3-3-3-2-3-2



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue763,749
Cost of Revenue-285,403
Gross Profit478,346478,346
 
Operating Income (+$)
Gross Profit478,346
Operating Expense-584,204
Operating Income179,545-105,858
 
Operating Expense (+$)
Research Development0
Selling General Administrative39,425
Selling And Marketing Expenses0
Operating Expense584,20439,425
 
Net Interest Income (+$)
Interest Income26
Interest Expense-1,988
Other Finance Cost-129
Net Interest Income-2,091
 
Pretax Income (+$)
Operating Income179,545
Net Interest Income-2,091
Other Non-Operating Income Expenses0
Income Before Tax (EBT)177,690179,545
EBIT - interestExpense = -1,988
136,881
138,869
Interest Expense1,988
Earnings Before Interest and Taxes (EBIT)0179,678
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax177,690
Tax Provision-40,814
Net Income From Continuing Ops136,876136,876
Net Income136,881
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,091
 

Technical Analysis of Laboratorios Farmaceuticos Rovi S.A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Laboratorios Farmaceuticos Rovi S.A. The general trend of Laboratorios Farmaceuticos Rovi S.A is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Laboratorios Farmaceuticos Rovi S.A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Laboratorios Farmaceuticos Rovi S.A Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Laboratorios Farmaceuticos Rovi S.A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 56.80 < 57.80 < 65.95.

The bearish price targets are: 53.95 > 53.60 > 51.50.

Know someone who trades $41L? Share this with them.👇

Laboratorios Farmaceuticos Rovi S.A Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Laboratorios Farmaceuticos Rovi S.A. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Laboratorios Farmaceuticos Rovi S.A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Laboratorios Farmaceuticos Rovi S.A. The current macd is 0.45071517.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Laboratorios Farmaceuticos Rovi S.A price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Laboratorios Farmaceuticos Rovi S.A. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Laboratorios Farmaceuticos Rovi S.A price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Laboratorios Farmaceuticos Rovi S.A Daily Moving Average Convergence/Divergence (MACD) ChartLaboratorios Farmaceuticos Rovi S.A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Laboratorios Farmaceuticos Rovi S.A. The current adx is 21.50.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Laboratorios Farmaceuticos Rovi S.A shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Laboratorios Farmaceuticos Rovi S.A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Laboratorios Farmaceuticos Rovi S.A. The current sar is 53.72.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Laboratorios Farmaceuticos Rovi S.A Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Laboratorios Farmaceuticos Rovi S.A. The current rsi is 61.90. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Laboratorios Farmaceuticos Rovi S.A Daily Relative Strength Index (RSI) ChartLaboratorios Farmaceuticos Rovi S.A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Laboratorios Farmaceuticos Rovi S.A. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Laboratorios Farmaceuticos Rovi S.A price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Laboratorios Farmaceuticos Rovi S.A Daily Stochastic Oscillator ChartLaboratorios Farmaceuticos Rovi S.A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Laboratorios Farmaceuticos Rovi S.A. The current cci is 63.55.

Laboratorios Farmaceuticos Rovi S.A Daily Commodity Channel Index (CCI) ChartLaboratorios Farmaceuticos Rovi S.A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Laboratorios Farmaceuticos Rovi S.A. The current cmo is 31.70.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Laboratorios Farmaceuticos Rovi S.A Daily Chande Momentum Oscillator (CMO) ChartLaboratorios Farmaceuticos Rovi S.A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Laboratorios Farmaceuticos Rovi S.A. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Laboratorios Farmaceuticos Rovi S.A Daily Williams %R ChartLaboratorios Farmaceuticos Rovi S.A Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi S.A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Laboratorios Farmaceuticos Rovi S.A. The current atr is 0.59222795.

Laboratorios Farmaceuticos Rovi S.A Daily Average True Range (ATR) ChartLaboratorios Farmaceuticos Rovi S.A Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Laboratorios Farmaceuticos Rovi S.A. The current obv is -3.

Laboratorios Farmaceuticos Rovi S.A Daily On-Balance Volume (OBV) ChartLaboratorios Farmaceuticos Rovi S.A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Laboratorios Farmaceuticos Rovi S.A. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Laboratorios Farmaceuticos Rovi S.A Daily Money Flow Index (MFI) ChartLaboratorios Farmaceuticos Rovi S.A Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Laboratorios Farmaceuticos Rovi S.A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Laboratorios Farmaceuticos Rovi S.A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Laboratorios Farmaceuticos Rovi S.A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.895
Ma 20Greater thanMa 5055.210
Ma 50Greater thanMa 10053.662
Ma 100Greater thanMa 20052.864
OpenGreater thanClose55.550
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Laboratorios Farmaceuticos Rovi S.A with someone you think should read this too:
  • Are you bullish or bearish on Laboratorios Farmaceuticos Rovi S.A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Laboratorios Farmaceuticos Rovi S.A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Laboratorios Farmaceuticos Rovi S.A

I send you an email if I find something interesting about Laboratorios Farmaceuticos Rovi S.A.


Comments

How you think about this?

Leave a comment

Stay informed about Laboratorios Farmaceuticos Rovi S.A.

Receive notifications about Laboratorios Farmaceuticos Rovi S.A in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.